News & Events

News & Events2022-10-31T18:45:01+00:00
1701, 2023

Scientists develop novel mRNA delivery method using extracellular vesicles

January 17th, 2023|mRNA therapeutics|

In the study, published in Nature Biomedical Engineering, researchers from MD Anderson Cancer Center use EV-encapsulated mRNA to initiate and sustain collagen production for several months in the cells of photoaged skin in laboratory models. It is the first therapy to demonstrate this ability and represents a proof-of-concept for deploying the EV mRNA therapy...

1312, 2022

ASGCT Members Provide Recommendations During FDA Liaison Meeting

December 13th, 2022|Gene & Cell Therapy Testing|

ASGCT held its fifth annual liaison meeting with FDA CBER’s Office of Tissues and Advanced Therapies (OTAT) on Nov. 14, 2022. A group of Society leaders and members gave two presentations to FDA on significant topics in the field, followed by a presentation from FDA. Dr. Keith Wonnacott, ASGCT’s Regulatory Affairs Committee Chair, chaired the meeting and moderated discussion...

612, 2022

CG Oncology advancing clinical-stage urologic oncology immunotherapy pipeline

December 6th, 2022|Gene & Cell Therapy Testing, News|

Company files its first Investigational New Drug application for its lead program KYV-101, a novel fully human CD19 CAR T-cell therapy, for the treatment of lupus nephritis. Kyverna’s therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate...

3011, 2022

Join Avance Biosciences at the Gene Therapy Analytical Development Summit Nov 28 – Dec 1 2022

November 30th, 2022|Gene & Cell Therapy Testing, News|

Avance offers a broad range of assay development services, including assay design, assay validation, sample testing, and technology transfer under GLP compliance to support IND-enabling and clinical studies. With decades of experience helping gene and cell therapy companies, Avance Biosciences has the...

911, 2022

CHOP Study Offers Proof of Concept for Treating Pediatric Brain Tumors with Immunotherapy

November 9th, 2022|Gene & Cell Therapy Testing, News|

Although immunotherapy has revolutionized the treatment of many blood cancers, the field has encountered challenges developing similar treatments for solid tumors. When it comes to pediatric brain tumors, which are the leading cause of cancer death in children, challenges include...